Ensysce Biosciences Inc. 已获得美国国家药物滥用研究所(NIDA)一笔价值530万美元的拨款分期款项。这笔资金标志着该公司一项总额达1500万美元的多年期联邦资助项目圆满完成。该资助旨在支持公司推进其创新药物研发平台。
Ensysce Biosciences Inc. 已获得美国国家药物滥用研究所(NIDA)一笔价值530万美元的拨款分期款项。这笔资金标志着该公司一项总额达1500万美元的多年期联邦资助项目圆满完成。该资助旨在支持公司推进其创新药物研发平台。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.